Scott Gottlieb: Market Dynamics and Drug Innovation
Former FDA Commissioner Dr. Scott Gottlieb joins ‘Squawk Box’ to discuss the impact of SCOTUS tariff ruling on the pharmaceutical industry, news of Novo Nordisk’s…
Thought Leader: Scott Gottlieb
Mark Halperin on Trump’s Second Term
2WAY TONIGHT with Mark Halperin. Every weekday evening Mark and our special guests discuss President Trump’s second term, Democrat realignment & the day’s political news.…
Thought Leader: Protected: Mark Halperin
Mark Esper: Navigating U.S.–Iran Tensions Under Domestic Pressure
Mark Esper, former Defense secretary, joins ‘Money Movers’ to discuss the tensions between the U.S. and Iran. The Honorable Mark Esper served as U.S. Secretary…
Thought Leader: Mark Esper
Dr. Sanjay Gupta: How Hibernation Could Redefine Medicine
Animals can hibernate, slowing down most metabolic functions — heart rate, blood flow, brain activity, and body temperature — then waking as if nothing happened. Humans have…
Thought Leader: Sanjay Gupta
Michael Auslin: Getting the Word Out
Michael Auslin in the Philadelphia Daily News on the lasting significance of the Declaration of Independence. One of America’s leading historians, Michael Auslin…
Thought Leader: Michael Auslin
Mark Halperin: How to Stay Ahead of the AI Revolution
On a new episode of “Next Up with Mark Halperin,” Mark’s reported monologue breaks down why the AI revolution is bigger than most people realize…
Thought Leader: Protected: Mark Halperin
Niall Ferguson: Welcome to Cold War Two
Are we living in the Second Cold War? And if so, what can we learn from the last one that might help us through it?…
Thought Leader: Niall Ferguson
Mark Esper on Iran and U.S. Security Challenges
“Balance of Power: Late Edition” focuses on the intersection of politics and global business. On today’s show, former Secretary of Defense Mark Esper discusses the…
Thought Leader: Mark Esper
Mark Halperin: Who’s Up for the Democrats in 2028?
The midterm elections are less than nine months away, which means the long presidential campaign will likely kick off in the coming months. While no…
Thought Leader: Protected: Mark Halperin
Michael Auslin’s Review of The Intelligence Intellectuals
In his review of The Intelligence Intellectuals, Michael Auslin examines Peter C. Grace’s account of how elite social scientists helped reshape the CIA in the…
Thought Leader: Michael Auslin
Mark Esper: Can the Defense Industrial Base Meet the Moment?
Mark Esper, former U.S. Secretary of Defense and now a Managing Partner at Red Cell Partners, joins us to examine the implications, risks and opportunities…
Thought Leader: Mark Esper
Michael Osterholm: FDA Declines Moderna’s mRNA Flu Vaccine
The U.S. Food and Drug Administration announced recently that it will not review Moderna’s mRNA flu vaccine, despite late-stage trials showing it was safe and…
Thought Leader: Michael Osterholm